Compared with the other medications, people taking the GLP-1 drugs had a reduced risk of addiction: 18% for alcohol, 14% for cannabis, 20% for both cocaine and nicotine and 25% for opioids
The pivotal SURMOUNT and SURPASS trial programs primarily focused on weight loss and glycemic outcomes, with reproductive health not designated as a primary endpoint
Most GLP-1a weight loss and type diabetes medications require a prior authorization (PA) from the insurance provider: FDA-approved weight loss medications: Contrave, Saxenda (liraglutide), Wegovy (semaglutide) Zepbound (tirzepatide) FDA-approved Diabetes medications: Rybelsis, Victoza (liraglutide), Ozempic (semaglutide), or Mounjaro (tirzepatide) If your insurance company says that they cover FDA-approved diabetes medications, it suggests coverage for patients with type 2 diabetes
This does not automatically mean compounded semaglutide is unsafe
What are HSA- or FSA-eligible expenses